A share price of Caredx Inc [CDNA] is currently trading at $8.92, up 7.86%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CDNA shares have gain 9.72% over the last week, with a monthly amount drifted -18.24%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 21, February 2024, CareDx to Report Fourth Quarter and Full Year 2023 Financial Results. In a post published today on Yahoo Finance, CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced it will report financial results for the fourth quarter and full year 2023 after market close on Wednesday, February 28, 2024. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
From an analyst’s perspective:
Caredx Inc [NASDAQ: CDNA] stock has seen the most recent analyst activity on November 09, 2023, when Stephens upgraded its rating to a Overweight but kept the price target unchanged to $10 for it. Previously, Raymond James upgraded its rating to Outperform on August 15, 2023, and kept the price target unchanged to $12. On May 11, 2023, downgrade downgraded it’s rating to Neutral. Stephens downgraded its rating to a Equal-Weight and decreased its price target to $9 on March 07, 2023. Raymond James downgraded its rating to a Mkt Perform. Craig Hallum downgraded its rating to Hold for this stock on March 03, 2023, and downed its price target to $9. In a note dated April 25, 2022, Stephens initiated an Overweight rating and provided a target price of $50 on this stock.
Caredx Inc experienced fluctuations in its stock price throughout the past year between $4.80 and $17.89. Currently, Wall Street analysts expect the stock to reach $39.5 within the next 12 months. Caredx Inc [NASDAQ: CDNA] shares were valued at $8.92 at the most recent close of the market. An investor can expect a potential return of 342.83% based on the average CDNA price forecast.
Analyzing the CDNA fundamentals
Trailing Twelve Months sales for Caredx Inc [NASDAQ:CDNA] were 297.14M which represents -15.33% decline. Gross Profit Margin for this corporation currently stands at -0.03% with Operating Profit Margin at -0.22%, Pretax Profit Margin comes in at -0.24%, and Net Profit Margin reading is -0.51%. To continue investigating profitability, this company’s Return on Assets is posted at -1.53, Equity is -2.61 and Total Capital is -22.65. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -6.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 8.44 points at the first support level, and at 7.95 for the second support level. However, for the 1st resistance point, the stock is sitting at 9.18, and for the 2nd resistance point, it is at 9.43.
Caredx Inc [CDNA] reported earnings per share of -$0.18 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.39/share, meaning a difference of $0.21 and a surprise factor of 53.80%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$0.18 per share as compared to estimates of -$0.31 per share, a difference of $0.13 representing a surprise of 41.90%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Caredx Inc [NASDAQ:CDNA] is 4.75. Also, the Quick Ratio is 4.50, while the Cash Ratio stands at 0.05. Considering the valuation of this stock, the price to sales ratio is 1.62, the price to book ratio is 1.23.
Transactions by insiders
Recent insider trading involved Seeto Reginald,, that happened on Oct 02 when 2818.0 shares were sold., Seeto Reginald completed a deal on Sep 05 to sell 2819.0 shares. Meanwhile, Seeto Reginald sold 576.0 shares on Aug 14.
